"
A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer"
written by Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama,
published by
Advances in Lung Cancer,
Vol.3 No.1, 2014
has been cited by the following article(s):